634 related articles for article (PubMed ID: 17108779)
1. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
2. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
4. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
5. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
[TBL] [Abstract][Full Text] [Related]
6. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
Lamers CG; Van Tongeren JH
Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
[TBL] [Abstract][Full Text] [Related]
8. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
Mihas AA; Hirschowitz BI; Gibson RG
Digestion; 1978; 17(1):1-10. PubMed ID: 627316
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls.
Kuiper P; Biemond I; Masclee AA; Jansen JB; Verspaget HW; Lamers CB
Pancreatology; 2010; 10(1):14-8. PubMed ID: 20299818
[TBL] [Abstract][Full Text] [Related]
10. Serum gastrin response to secretin after vagotomy.
Feldman M; Walsh JH; Richardson CT
Dig Dis Sci; 1980 Dec; 25(12):921-3. PubMed ID: 7449589
[TBL] [Abstract][Full Text] [Related]
11. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
12. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
Jansen JB; Lamers CB
Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four provocative tests for the diagnosis of gastrinoma.
Romanus ME; Neal JA; Dilley WG; Leight GS; Linehan WM; Santen RJ; Farndon JR; Jones RS; Wells SA
Ann Surg; 1983 May; 197(5):608-17. PubMed ID: 6847280
[TBL] [Abstract][Full Text] [Related]
14. Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature.
Roy PK; Venzon DJ; Feigenbaum KM; Koviack PD; Bashir S; Ojeaburu JV; Gibril F; Jensen RT
Medicine (Baltimore); 2001 May; 80(3):189-222. PubMed ID: 11388095
[TBL] [Abstract][Full Text] [Related]
15. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of initial fasting serum gastrin levels in patients with Zollinger-Ellison syndrome.
Berger AC; Gibril F; Venzon DJ; Doppman JL; Norton JA; Bartlett DL; Libutti SK; Jensen RT; Alexander HR
J Clin Oncol; 2001 Jun; 19(12):3051-7. PubMed ID: 11408501
[TBL] [Abstract][Full Text] [Related]
17. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
Wada M; Komoto I; Doi R; Imamura M
World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
[TBL] [Abstract][Full Text] [Related]
18. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
Rigaud D; Accary JP; Mignon M; Bonfils S
Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
[TBL] [Abstract][Full Text] [Related]
19. The early diagnosis of gastrinoma.
Modlin IM; Jaffe BM; Sank A; Albert D
Ann Surg; 1982 Nov; 196(5):512-7. PubMed ID: 7125738
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of the secretin provocation test.
Lamers CB
J Clin Gastroenterol; 1981 Sep; 3(3):255-9. PubMed ID: 7288118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
